ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/10/15 | 4,210 | 4,220 | 4,110 | 4,125 | -135 | -3.2% | 638,800 |
| 2018/10/12 | 4,170 | 4,270 | 4,135 | 4,260 | +55 | +1.3% | 752,400 |
| 2018/10/11 | 4,110 | 4,225 | 4,090 | 4,205 | -110 | -2.5% | 799,200 |
| 2018/10/10 | 4,375 | 4,415 | 4,280 | 4,315 | +40 | +0.9% | 602,700 |
| 2018/10/09 | 4,390 | 4,420 | 4,255 | 4,275 | -215 | -4.8% | 817,900 |
| 2018/10/05 | 4,565 | 4,570 | 4,465 | 4,490 | -165 | -3.5% | 602,400 |
| 2018/10/04 | 4,655 | 4,730 | 4,625 | 4,655 | ±0 | ±0% | 597,400 |
| 2018/10/03 | 4,660 | 4,710 | 4,640 | 4,655 | -70 | -1.5% | 700,300 |
| 2018/10/02 | 4,690 | 4,750 | 4,595 | 4,725 | +100 | +2.2% | 1,160,100 |
| 2018/10/01 | 4,580 | 4,665 | 4,570 | 4,625 | +95 | +2.1% | 910,900 |
| 2018/09/28 | 4,490 | 4,575 | 4,485 | 4,530 | +65 | +1.5% | 802,200 |
| 2018/09/27 | 4,520 | 4,570 | 4,465 | 4,465 | -40 | -0.9% | 733,100 |
| 2018/09/26 | 4,430 | 4,515 | 4,400 | 4,505 | +110 | +2.5% | 827,500 |
| 2018/09/25 | 4,265 | 4,415 | 4,255 | 4,395 | +130 | +3% | 759,500 |
| 2018/09/21 | 4,295 | 4,335 | 4,255 | 4,265 | +20 | +0.5% | 387,000 |
| 2018/09/20 | 4,225 | 4,260 | 4,200 | 4,245 | +25 | +0.6% | 371,700 |
| 2018/09/19 | 4,285 | 4,295 | 4,175 | 4,220 | -35 | -0.8% | 639,300 |
| 2018/09/18 | 4,105 | 4,280 | 4,080 | 4,255 | +150 | +3.7% | 722,400 |
| 2018/09/14 | 4,100 | 4,135 | 4,040 | 4,105 | +75 | +1.9% | 539,100 |
| 2018/09/13 | 4,000 | 4,115 | 3,965 | 4,030 | -20 | -0.5% | 657,700 |
| 2018/09/12 | 4,090 | 4,100 | 4,005 | 4,050 | -10 | -0.2% | 541,700 |
| 2018/09/11 | 3,950 | 4,065 | 3,915 | 4,060 | +80 | +2% | 575,100 |
| 2018/09/10 | 4,000 | 4,090 | 3,975 | 3,980 | -35 | -0.9% | 521,800 |
| 2018/09/07 | 4,050 | 4,100 | 3,985 | 4,015 | -115 | -2.8% | 638,400 |
| 2018/09/06 | 4,280 | 4,280 | 4,100 | 4,130 | -180 | -4.2% | 765,400 |
| 2018/09/05 | 4,355 | 4,370 | 4,285 | 4,310 | -60 | -1.4% | 505,900 |
| 2018/09/04 | 4,205 | 4,385 | 4,195 | 4,370 | +165 | +3.9% | 887,600 |
| 2018/09/03 | 4,270 | 4,310 | 4,175 | 4,205 | -135 | -3.1% | 679,100 |
| 2018/08/31 | 4,280 | 4,365 | 4,280 | 4,340 | +5 | +0.1% | 529,300 |
| 2018/08/30 | 4,350 | 4,365 | 4,300 | 4,335 | +10 | +0.2% | 601,500 |
| 2018/08/29 | 4,280 | 4,350 | 4,250 | 4,325 | +15 | +0.3% | 501,700 |
| 2018/08/28 | 4,285 | 4,370 | 4,265 | 4,310 | +45 | +1.1% | 648,200 |
| 2018/08/27 | 4,230 | 4,275 | 4,180 | 4,265 | +55 | +1.3% | 524,400 |
| 2018/08/24 | 4,210 | 4,255 | 4,155 | 4,210 | +45 | +1.1% | 730,800 |
| 2018/08/23 | 4,055 | 4,175 | 4,030 | 4,165 | +85 | +2.1% | 560,000 |
| 2018/08/22 | 3,980 | 4,150 | 3,930 | 4,080 | +125 | +3.2% | 1,143,400 |
| 2018/08/21 | 3,800 | 3,970 | 3,800 | 3,955 | +145 | +3.8% | 613,100 |
| 2018/08/20 | 3,885 | 3,920 | 3,780 | 3,810 | -15 | -0.4% | 617,900 |
| 2018/08/17 | 3,745 | 3,845 | 3,720 | 3,825 | +140 | +3.8% | 757,400 |
| 2018/08/16 | 3,730 | 3,775 | 3,625 | 3,685 | -95 | -2.5% | 869,600 |
| 2018/08/15 | 3,760 | 3,835 | 3,625 | 3,780 | +35 | +0.9% | 1,185,200 |
| 2018/08/14 | 3,935 | 3,935 | 3,715 | 3,745 | -155 | -4% | 1,539,700 |
| 2018/08/13 | 4,210 | 4,225 | 3,880 | 3,900 | -380 | -8.9% | 1,307,800 |
| 2018/08/10 | 4,420 | 4,440 | 4,265 | 4,280 | +105 | +2.5% | 1,384,600 |
| 2018/08/09 | 4,195 | 4,200 | 4,110 | 4,175 | -35 | -0.8% | 483,200 |
| 2018/08/08 | 4,155 | 4,235 | 4,155 | 4,210 | +75 | +1.8% | 485,200 |
| 2018/08/07 | 4,120 | 4,185 | 4,100 | 4,135 | +15 | +0.4% | 542,600 |
| 2018/08/06 | 4,110 | 4,175 | 4,090 | 4,120 | -10 | -0.2% | 638,300 |
| 2018/08/03 | 4,165 | 4,220 | 4,125 | 4,130 | -40 | -1% | 710,900 |
| 2018/08/02 | 4,175 | 4,210 | 4,080 | 4,170 | -20 | -0.5% | 871,500 |
1601～
1650
件表示中 / 2911件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | - | +5.0% | +1.5% | - | - | - |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | - | +26.8% | - | - | - | - |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | - | +20.9% | +87.3% | - | - | - |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | - | +8.0% | -15.3% | - | - | - |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | - | +4.0% | +25.4% | - | - | - |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム
